Allogene Therapeutics, Inc. (ALLO) earnings
Quarterly results of Allogene Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Allogene Therapeutics, Inc. is expected to report around March 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Allogene Therapeutics, Inc. reported revenue of $0 and a net loss of $50.4M.
Diluted earnings per share were -$0.15.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $0 | - | -$50.4M | -$0.15 |
| Q2 FY2026 | $4.6M | - | -$42.7M | -$0.13 |
| Q1 FY2026 | - | - | -$42.6M | -$0.18 |
| Q4 FY2025 | $0 | - | -$38.8M | - |
| Q3 FY2025 | $0 | - | -$41.4M | -$0.19 |
| Q2 FY2025 | $0 | - | -$50.9M | -$0.23 |
| Q1 FY2025 | $0 | - | -$59.7M | -$0.28 |
| Q4 FY2024 | $0 | - | -$59.9M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
When is Allogene Therapeutics, Inc.'s next earnings date?
Allogene Therapeutics, Inc. is expected to report around March 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Allogene Therapeutics, Inc.'s latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, Allogene Therapeutics, Inc. reported revenue of $0 and a net loss of $50.4M. The figures come from its filing with the SEC.
Get an email when ALLO reports
Follow ALLO and we email you its next results the day they are filed, with the numbers explained.